Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fender

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Therapie|July 27, 2001
[Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines]P Fender, J Guilhot, B Tilly, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 9, 2002
[Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program]B Tilly, J Guilhot, B Salanave, et al.
Virologie (Montrouge, France)|September 22, 2022
[Adenoviruses structure]M El Bakkouri, C M Fabry, P Fender, et al.
The Journal of Gene Medicine|January 4, 2006
Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptorsA Garcel, E Gout, J Timmins, et al.
Journal of Biomedicine & Biotechnology|March 13, 2010
The adenovirus type 3 dodecahedron's RGD loop comprises an HSPG binding site that influences integrin bindingE Gout, G Schoehn, D Fenel, et al.
Diabetes & Metabolism|September 30, 2000
[Pharmacoepidemiology of diabetes: assessment of good use of oral antidiabetic drugs]F Vauzelle-Kervroëdan, F Javoy, A Forhan, et al.
Nature Biotechnology|January 1, 1997
Adenovirus dodecahedron, a new vector for human gene transferP Fender, R W Ruigrok, E Gout, et al.
Diabetes & Metabolism|August 12, 1999
[Pharmacoepidemiology of diabetes: contribution of a survey of health insurance cases]F Vauzellé-Kervroedan, A Forhan, F Javoy, et al.
Diabetes & Metabolism|September 30, 2000
[Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998]A Weill, P Ricordeau, N Vallier, et al.
Diabetes & Metabolism|September 30, 2000
[Totally reimbursed care for type 2 diabetes in 1994: characteristics and follow-up]F Vauzelle-Kervroëdan, S Cherou-Debregeas, A Forhan, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Therapie|July 27, 2001
[Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines]P Fender, J Guilhot, B Tilly, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 9, 2002
[Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program]B Tilly, J Guilhot, B Salanave, et al.
Virologie (Montrouge, France)|September 22, 2022
[Adenoviruses structure]M El Bakkouri, C M Fabry, P Fender, et al.
The Journal of Gene Medicine|January 4, 2006
Protein transduction into human cells by adenovirus dodecahedron using WW domains as universal adaptorsA Garcel, E Gout, J Timmins, et al.
Journal of Biomedicine & Biotechnology|March 13, 2010
The adenovirus type 3 dodecahedron's RGD loop comprises an HSPG binding site that influences integrin bindingE Gout, G Schoehn, D Fenel, et al.
Diabetes & Metabolism|September 30, 2000
[Pharmacoepidemiology of diabetes: assessment of good use of oral antidiabetic drugs]F Vauzelle-Kervroëdan, F Javoy, A Forhan, et al.
Nature Biotechnology|January 1, 1997
Adenovirus dodecahedron, a new vector for human gene transferP Fender, R W Ruigrok, E Gout, et al.
Diabetes & Metabolism|August 12, 1999
[Pharmacoepidemiology of diabetes: contribution of a survey of health insurance cases]F Vauzellé-Kervroedan, A Forhan, F Javoy, et al.
Diabetes & Metabolism|September 30, 2000
[Modalities of follow-up on non-insulin treated diabetics treated in metropolitan France in 1998]A Weill, P Ricordeau, N Vallier, et al.
Diabetes & Metabolism|September 30, 2000
[Totally reimbursed care for type 2 diabetes in 1994: characteristics and follow-up]F Vauzelle-Kervroëdan, S Cherou-Debregeas, A Forhan, et al.
Pageof 5